Allianz’s, Buyback

Allianz’s €2.5bn Buyback Gathers Pace Even as Wall Street Sees a 23% Overvaluation

Published on 07/13/2026 at 18:07 | Redaktion boerse-global.de

Allianz shares near year-high at €423, but Jefferies' target of €325 signals overvaluation. Aggressive buyback pace, overbought RSI, and departure of digital chief add to the debate.

Allianz Stock Rally Faces Analyst Skepticism Amid Aggressive Buyback
Allianz’s €2.5bn Buyback Gathers Pace Even as Wall Street Sees a 23% Overvaluation Illustration mit AI erstellt übermittelt durch boerse-global.de

The disconnect at Allianz is widening by the day. The insurer’s stock recently came within a whisker of €425.50, its highest level in a year, while one prominent analyst insists the fair value sits nearly €100 lower. That tension — between a management team buying back shares at full tilt and an outside valuation that calls the rally overdone — is now shaping the investment debate around the Dax heavyweight.

The buyback engine is running hot. Allianz launched a €2.5bn repurchase programme on 13 March, with a deadline of 31 December 2026. By 3 July it had spent roughly €1.5bn to buy back almost 3.95 million own shares — 60% of the maximum volume with only 38% of the allotted time gone. The pace even accelerated during the most recent reporting week, when the average buyback price hit €414.07, the highest yet in the programme. That willingness to keep buying through rising prices signals deep conviction inside the boardroom that the equity remains cheap.

Underlying numbers give that confidence a visible anchor. In the first quarter, Allianz posted an operating profit of €4.517bn, up 6.6% year-on-year. The solvency ratio stood at 221%, far above regulatory floors, and management has reaffirmed a full-year operating target of €17.4bn, with a €1bn tolerance band. For income-focused shareholders, the dividend of €17.10 per share for 2025 translates into a yield of 4.07% at current levels. Including the buyback, total capital returned in 2026 reaches at least 5.6%.

Should investors sell immediately? Or is it worth buying Allianz?

Yet on the other side of the Atlantic, Jefferies remains unmoved. Analyst Philip Kett reiterated a “Hold” rating over the weekend, with a price target of just €325 — 23% below Monday’s close of €423.10. In the same note, Kett observed that European insurers gained 7.5% on average over the past month, with reinsurers leading and life insurers lagging, but he sees no fundamental catalyst that would justify a further rerating for Allianz.

Adding to the narrative of transformation, Allianz is losing a key figure in its digital overhaul. Stefan Weih, who spent years modernising legacy IT systems and embedding artificial intelligence into operations at Allianz Partners, will leave on 15 July to join Generali Deutschland in a newly created role as Head of AI, Digitalization & Process Mining. His departure comes just days after Allianz Partners announced it would cut up to 1,800 jobs as part of its own AI-driven restructuring. The move highlights the intensifying war for data-science talent across the insurance sector.

Technically, the stock is flashing warning lights. The 14-day relative strength index stands at 75.7, firmly in overbought territory. The share now trades 7.66% above its 50-day moving average and 12.35% above the 200-day line. On a one-month view, the gain is 9.36%; year-to-date it has climbed 8.85%, and over 12 months the advance reaches 22.18%. To put that in context, the stock is roughly 26% above its 52-week low of €334.90 from last August.

The next major test for Allianz comes on 7 August, when half-year results are due. Until then, weekly buyback disclosures will remain the tightest real-time gauge of management sentiment. If the current spending rate persists, the programme could exhaust its full envelope well before year-end, injecting further demand into a market that is already pricing the stock for perfection — and ignoring an analyst who sees a very different floor.

Ad

Allianz Stock: New Analysis - 13 July

Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Allianz analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0008404005 | ALLIANZ’S | boerse | 69761235 |